NCT07166731View on ClinicalTrials.gov

High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)

Not yet recruitingOBSERVATIONAL
Enrollment

536

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

October 31, 2031

Study Completion Date

January 1, 2032

Conditions
Carotid Artery DiseaseSymptomatic Carotid Artery StenosisCarotid Artery StentingCarotid Plaque ImagingEmbolic Stroke of Undetermined SourceCarotid Artery Thrombosis
Sponsors

Lead Sponsor

Acandis GmbH
All Listed Sponsors
lead

Acandis GmbH

INDUSTRY

NCT07166731 - High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC) | Biotech Hunter | Biotech Hunter